Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FN0N5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $72,380
Award facts
- Contract value 100% obligated
- $72,379.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $72,379.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 20, 2026, for the supply of Dupixent 300 mg/2 ml pen injections. This is a non-set-aside competitive award with a completion date of January 21, 2026, with performance executed from the awardee's facility in Conshohocken, Pennsylvania. The contract is issued as a delivery order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2031, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, leverages its extensive federal procurement capabilities and established relationship with DLA to fulfill this medical supply requirement. The company's demonstrated expertise in delivering a diverse portfolio of pharmaceutical products—ranging from specialty medications and brand-name drugs to vaccines and medical devices—across multiple therapeutic domains positions it to support the military healthcare system's pharmaceutical needs. This delivery order represents one of numerous task orders executed under the company's prime IDC with DLA, reflecting its ongoing role as a critical vendor for federal medical procurement, particularly for military treatment facilities and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FN0N5?
SPE2DR26FN0N5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FN0N5 worth?
The government has obligated $72,380 on SPE2DR26FN0N5.
Is contract SPE2DR26FN0N5 an order under another contract?
Yes. SPE2DR26FN0N5 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FN0N5 competed?
The extent of competition for SPE2DR26FN0N5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award